Intravenous self-administration of entactogen-class stimulants in male rats

Neuropharmacology

Volumn 99, Issue , 2015, Pages 538-545

  Vandewater, Sophia A ^a   Creehan, Kevin M ^a   Taffe, Michael A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Bath salts; Drug addiction; Ecstasy; Reward; Substance abuse

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4' METHYLMETHCATHINONE; COCAINE; METHAMPHETAMINE; METHYLONE; CENTRAL STIMULANT AGENT; MIDOMAFETAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; FIXED RATIO DOSE RESPONSE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; PROGRESSIVE RATIO DOSE RESPONSE; RAT; REINFORCEMENT; AMPHETAMINE DEPENDENCE; ANALOGS AND DERIVATIVES; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; INDWELLING CATHETER; INTRAVENOUS DRUG ADMINISTRATION; SEXUAL DEVELOPMENT; WISTAR RAT;

ADMINISTRATION, INTRAVENOUS; AMPHETAMINE-RELATED DISORDERS; ANIMALS; CATHETERS, INDWELLING; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; MALE; METHAMPHETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS, WISTAR; SELF ADMINISTRATION; SEX CHARACTERISTICS;

EID: 84940479394     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2015.08.030     Document Type: Article

References (63)

1. S.M. Aarde, D. Angrish, D.J. Barlow, M.J. Wright Jr., S.A. Vandewater, K.M. Creehan, K.L. Houseknecht, T.J. Dickerson, and M.A. Taffe Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats Addict. Biol. 18 2013 786 799
2. S.M. Aarde, P.K. Huang, K.M. Creehan, T.J. Dickerson, and M.A. Taffe The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats Neuropharmacology 71 2013 130 140
3. S.M. Aarde, P.K. Huang, T.J. Dickerson, and M.A. Taffe Binge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in rats Psychopharmacology 232 2015 1867 1877
4. S.M. Aarde, M.L. Miller, K.M. Creehan, S.A. Vandewater, and M.A. Taffe One day access to a running wheel reduces self-administration of d-methamphetamine, MDMA and methylone Drug Alcohol Depend. 151 2015 151 158
5. S.H. Ahmed, and G.F. Koob Transition from moderate to excessive drug intake: change in hedonic set point Science 282 1998 298 300
6. M. Angoa-Perez, M.J. Kane, D.I. Briggs, D.M. Francescutti, C.E. Sykes, M.M. Shah, D.M. Thomas, and D.M. Kuhn Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA J. Neurochem. 125 2013 102 110
7. M. Angoa-Pérez, M.J. Kane, D.M. Francescutti, K.E. Sykes, M.M. Shah, A.M. Mohammed, D.M. Thomas, and D.M. Kuhn Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum J. Neurochem. 120 2012 1097 1107
8. J.J. Anker, T.R. Baron, N.E. Zlebnik, and M.E. Carroll Escalation of methamphetamine self-administration in adolescent and adult rats Drug Alcohol Depend. 124 2012 149 153
9. K.T. Ball, K.M. Walsh, and G.V. Rebec Reinstatement of MDMA (ecstasy) seeking by exposure to discrete drug-conditioned cues Pharmacol. Biochem. Behav. 87 2007 420 425
10. M.H. Baumann, M.A. Ayestas Jr., J.S. Partilla, J.R. Sink, A.T. Shulgin, P.F. Daley, S.D. Brandt, R.B. Rothman, A.E. Ruoho, and N.V. Cozzi The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue Neuro Psychopharmacol. Off. Publ. Am. Coll. Neuro Psychopharmacol. 37 2012 1192 1203
11. M.H. Baumann, R.D. Clark, and R.B. Rothman Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain Pharmacol. Biochem. Behav. 90 2008 208 217
12. M.H. Baumann, J.S. Partilla, K.R. Lehner, E.B. Thorndike, A.F. Hoffman, M. Holy, R.B. Rothman, S.R. Goldberg, C.R. Lupica, H.H. Sitte, S.D. Brandt, S.R. Tella, N.V. Cozzi, and C.W. Schindler Powerful cocaine-like actions of 3,4-Methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 38 2013 552 562
13. J.S. Bonano, R.A. Glennon, L.J. De Felice, M.L. Banks, and S.S. Negus Abuse-related and abuse-limiting effects of methcathinone and the synthetic "bath salts" cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats Psychopharmacology 231 2014 199 207
14. S. Bradbury, J. Bird, J. Colussi-Mas, M. Mueller, G. Ricaurte, and S. Schenk Acquisition of MDMA self-administration: pharmacokinetic factors and MDMA-induced serotonin release Addict. Biol. 19 2014 874 884
15. J. Colussi-Mas, R.J. Wise, A. Howard, and S. Schenk Drug seeking in response to a priming injection of MDMA in rats: relationship to initial sensitivity to self-administered MDMA and dorsal striatal dopamine Int. J. Neuropsychopharmacol. 13 2010 1315 1327
16. K.M. Creehan, S.A. Vandewater, and M.A. Taffe Intravenous self-administration of mephedrone, methylone and MDMA in female rats Neuropharmacology 92 2015 90 97
17. R.I. Dafters Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats Psychopharmacology 114 1994 505 508
18. J.W. Dalley, K. Lääne, D.E.H. Theobald, Y. Peña, C.C. Bruce, A.C. Huszar, M. Wojcieszek, B.J. Everitt, and T.W. Robbins Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphetamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine Neuro Psychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 32 2007 1195 1206
19. P.I. Dargan, S. Albert, and D.M. Wood Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change QJM Mon. J. Assoc. Phys. 103 2010 875 879
20. R. De La Garza 2nd, K.R. Fabrizio, and A. Gupta Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns Psychopharmacology 189 2007 425 434
21. G. De Paoli, S.D. Brandt, and D.J. Pounder Mephedrone Banned but still available on the internet BMJ 342 2011 d1629
22. P. Deluca, Z. Davey, O. Corazza, L. Di Furia, M. Farre, L.H. Flesland, M. Mannonen, A. Majava, T. Peltoniemi, M. Pasinetti, C. Pezzolesi, N. Scherbaum, H. Siemann, A. Skutle, M. Torrens, P. van der Kreeft, E. Iversen, and F. Schifano Identifying emerging trends in recreational drug use; outcomes from the psychonaut web mapping project Prog. Neuro Psychopharmacol. Biol. Psychiatry 39 2012 221 226
23. B. den Hollander, S. Rozov, A.M. Linden, M. Uusi-Oukari, I. Ojanpera, and E.R. Korpi Long-term cognitive and neurochemical effects of "bath salt" designer drugs methylone and mephedrone Pharmacol. Biochem. Behav. 103 2013 501 509
24. J. Do, and S. Schenk Self-administered MDMA produces dose- and time-dependent serotonin deficits in the rat brain Addict. Biol. 18 2013 441 447
25. A.J. Eshleman, K.M. Wolfrum, M.G. Hatfield, R.A. Johnson, K.V. Murphy, and A. Janowsky Substituted methcathinones differ in transporter and receptor interactions Biochem. Pharmacol. 85 2013 1803 1815
26. W.E. Fantegrossi, T. Godlewski, R.L. Karabenick, J.M. Stephens, T. Ullrich, K.C. Rice, and J.H. Woods Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice Psychopharmacology 166 2003 202 211
27. A.A. Feduccia, N. Kongovi, and C.L. Duvauchelle Heat increases MDMA-enhanced NAcc 5-HT and body temperature, but not MDMA self-administration Eur. Neuropsychopharmacol. 20 2010 884 894
28. N. Granado, E. O'Shea, J. Bove, M. Vila, M.I. Colado, and R. Moratalla Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice J. Neurochem. 107 2008 1102 1112
29. G.C. Hadlock, K.M. Webb, L.M. McFadden, P.W. Chu, J.D. Ellis, S.C. Allen, D.M. Andrenyak, P.L. Vieira-Brock, C.L. German, K.M. Conrad, A.J. Hoonakker, J.W. Gibb, D.G. Wilkins, G.R. Hanson, and A.E. Fleckenstein 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse J. Pharmacol. Exp. Ther. 339 2011 530 536
30. P.K. Huang, S.M. Aarde, D. Angrish, K.L. Houseknecht, T.J. Dickerson, and M.A. Taffe Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats Drug Alcohol Depend. 126 2012 168 175
31. C.G. Jang, T. Whitfield, G. Schulteis, G.F. Koob, and S. Wee A dysphoric-like state during early withdrawal from extended access to methamphetamine self-administration in rats Psychopharmacology 225 2013 753 763
32. J. Kehr, F. Ichinose, S. Yoshitake, M. Goiny, T. Sievertsson, F. Nyberg, and T. Yoshitake Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats Br. J. Pharmacol. 164 2011 1949 1958
33. O. Kitamura, S. Wee, S.E. Specio, G.F. Koob, and L. Pulvirenti Escalation of methamphetamine self-administration in rats: a dose-effect function Psychopharmacology 186 2006 48 53
34. E.B. Larson, J.J. Anker, L.A. Gliddon, K.S. Fons, and M.E. Carroll Effects of estrogen and progesterone on the escalation of cocaine self-administration in female rats during extended access Exp. Clin. Psychopharmacol. 15 2007 461 471
35. R. Lopez-Arnau, J. Martinez-Clemente, D. Pubill, E. Escubedo, and J. Camarasa Serotonergic impairment and memory deficits in adolescent rats after binge exposure of methylone J. Psychopharmacol. 28 2014 1053 1063
36. K.J. Lusthof, R. Oosting, A. Maes, M. Verschraagen, A. Dijkhuizen, and A.G. Sprong A case of extreme agitation and death after the use of mephedrone in The Netherlands Forensic Sci. Int. 206 2011 e93 e95
37. J.E. Malberg, and L.S. Seiden Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat J. Neurosci. 18 1998 5086 5094
38. M.L. Miller, S.M. Aarde, A.Y. Moreno, K.M. Creehan, K.D. Janda, and M.A. Taffe Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats Drug Alcohol Depend. 153 2015 Aug 1 29 36
39. M.L. Miller, A.Y. Moreno, S.M. Aarde, K.M. Creehan, S.A. Vandewater, B.D. Vaillancourt, M.J. Wright Jr., K.D. Janda, and M.A. Taffe A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats Biol. Psychiatry 73 2013 721 728
40. M.L. Miller, B.D. Vaillancourt, M.J. Wright Jr., S.M. Aarde, S.A. Vandewater, K.M. Creehan, and M.A. Taffe Reciprocal inhibitory effects of intravenous d-methamphetamine self-administration and wheel activity in rats Drug Alcohol Depend. 121 2012 90 96
41. K. Moore, P.I. Dargan, D.M. Wood, and F. Measham Do novel psychoactive substances displace established club drugs, supplement them or act as drugs of initiation? The relationship between mephedrone, ecstasy and cocaine Eur. Addict. Res. 19 2013 276 282
42. C.P. Motbey, K.J. Clemens, N. Apetz, A.R. Winstock, J. Ramsey, K.M. Li, N. Wyatt, P.D. Callaghan, M.T. Bowen, J.L. Cornish, and I.S. McGregor High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine J. Psychopharmacol. 27 2013 823 836
43. A.C. Oakly, B.W. Brox, S. Schenk, and B.A. Ellenbroek A genetic deletion of the serotonin transporter greatly enhances the reinforcing properties of MDMA in rats Mol. Psychiatry 19 2014 534 535
44. M.M. Patel, D.W. Wright, J.J. Ratcliff, and M.A. Miller Shedding new light on the "safe" club drug: methylenedioxymethamphetamine (ecstasy)-related fatalities Acad. Emerg. Med. 11 2004 208 210
45. J.M. Pearson, T.L. Hargraves, L.S. Hair, C.J. Massucci, C.C. Frazee, U. Garg, and B.R. Pietak Three fatal intoxications due to methylone J. Anal. Toxicol. 36 2012 444 451
46. N.R. Richardson, and D.C. Roberts Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy J. Neurosci. Method. 66 1996 1 11
47. D.C. Roberts, R. Phelan, L.M. Hodges, M.M. Hodges, B. Bennett, S. Childers, and H. Davies Self-administration of cocaine analogs by rats Psychopharmacology 144 1999 389 397
48. S. Schenk, J. Colussi-Mas, J. Do, and J. Bird Profile of MDMA self-administration from a large cohort of rats: MDMA develops a profile of dependence with extended testing J. Drug Alcohol Res. 1 2012 1 6
49. S. Schenk, D. Gittings, M. Johnstone, and E. Daniela Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats Psychopharmacology 169 2003 21 27
50. S. Schenk, L. Hely, D. Gittings, B. Lake, and E. Daniela Effects of priming injections of MDMA and cocaine on reinstatement of MDMA- and cocaine-seeking in rats Drug Alcohol Depend. 96 2008 249 255
51. S. Schenk, L. Hely, B. Lake, E. Daniela, D. Gittings, and D.C. Mash MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding Eur. J. Neurosci. 26 2007 3229 3236
52. F. Schifano A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities Psychopharmacology 173 2004 242 248
53. M. Schwendt, A. Rocha, R.E. See, A.M. Pacchioni, J.F. McGinty, and P.W. Kalivas Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion J. Pharmacol. Exp. Ther. 331 2009 555 562
54. L. Simmler, T. Buser, M. Donzelli, Y. Schramm, L.H. Dieu, J. Huwyler, S. Chaboz, M. Hoener, and M. Liechti Pharmacological characterization of designer cathinones in vitro Br. J. Pharmacol. 168 2013 458 470
55. L.D. Simmler, A. Rickli, M.C. Hoener, and M.E. Liechti Monoamine transporter and receptor interaction profiles of a new series of designer cathinones Neuropharmacology 79 2014 152 160
56. M.A. Taffe, S.A. Davis, J. Yuan, R. Schroeder, G. Hatzidimitriou, L.H. Parsons, G.A. Ricaurte, and L.H. Gold Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to serotonergic challenge Neuropsychopharmacol. Off. Publ. Am. Coll. Neuro Psychopharmacol. 27 2002 993 1005
57. M.A. Taffe, S. Huitron-Resendiz, R. Schroeder, L.H. Parsons, S.J. Henriksen, and L.H. Gold MDMA exposure alters cognitive and electrophysiological sensitivity to rapid tryptophan depletion in rhesus monkeys Pharmacol. Biochem. Behav. 76 2003 141 152
58. H. Torrance, and G. Cooper The detection of mephedrone (4-methylmethcathinone) in 4 fatalities in Scotland Forensic Sci. Int. 202 2010 e62 e63
59. L.R. Watterson, L. Hood, K. Sewalia, S.E. Tomek, S. Yahn, C.T. Johnson, S. Wegner, B.E. Blough, J.A. Marusich, and M.F. Olive The reinforcing and rewarding effects of methylone, a synthetic cathinone commonly found in "Bath salts" J. Addict. Res. Ther. 002 S9 2012 1 8
60. S. Wee, K.G. Anderson, M.H. Baumann, R.B. Rothman, B.E. Blough, and W.L. Woolverton Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs J. Pharmacol. Exp. Ther. 313 2005 848 854
61. S. Wee, and W.L. Woolverton Self-administration of mixtures of fenfluramine and amphetamine by rhesus monkeys Pharmacol. Biochem. Behav. 84 2006 337 343
62. A.R. Winstock, L.R. Mitcheson, P. Deluca, Z. Davey, O. Corazza, and F. Schifano Mephedrone, new kid for the chop? Addiction 106 2011 154 161 (Abingdon, England)
63. M.J. Wright Jr., D. Angrish, S.M. Aarde, D.J. Barlow, M.W. Buczynski, K.M. Creehan, S.A. Vandewater, L.H. Parsons, K.L. Houseknecht, T.J. Dickerson, and M.A. Taffe Effect of ambient temperature on the thermoregulatory and locomotor stimulant effects of 4-methylmethcathinone in Wistar and Sprague-Dawley rats PloS One 7 2012 e44652